No correlation between estimated and actual glomerular filtration rates in pediatric oncology patients by Uzunova, Lena et al.
No correlation between estimated and actual glomerular filtration rates in pediatric 
oncology patients. 
 
Lena Uzunova
1
, Anny Wong
1
, Boo Messahel
1
, Matthew J. Murray
1,2 
 
1
Department of Paediatric Haematology and Oncology, Addenbrooke’s Hospital, Cambridge, 
CB2 0QQ, UK 
2
Department of Paediatrics, University of Cambridge, Addenbrooke’s Hospital, Cambridge, 
CB2 0QQ, UK 
 
Correspondence: Dr Matthew Murray, Department of Paediatric Haematology and 
Oncology, Addenbrooke’s Hospital, Cambridge, UK. Telephone: 0044 1223 256298; Fax: 
01223 586 794; email: mjm16@cam.ac.uk  
 
Funding: none 
 
Conflict of interest: none 
 
Word count: 507 
 
 
 2 
Background 
We read with interest the article by Bernhardt et al [1], describing a retrospective single 
institution study comparing estimated glomerular filtration rate (eGFR) with actual GFR in 
children with cancer. As glomerular filtration is a key route of excretion of many 
chemotherapy agents, its accurate determination is essential in order to allow appropriate 
dosing of such drugs. Formal GFR measurement requires the use of the radioisotope 
technetium-99m-diethylenetriaminepentacetic acid (DTPA) [2], and repeated serum 
measurements, to determine its clearance. It has therefore been suggested that formulae 
estimating the GFR from parameters such as serum creatinine and patient height are simpler, 
cheaper, avoid use of radioisotopes and may be sufficient [2]. Bernhardt et al assessed three 
estimation formulae (Schwartz, revised Schwartz and Counahan-Barratt) and showed that 
none provided a reliable estimate of actual GFR [1]. We recently performed a similar 
retrospective single institution study, and share our timely and corroborative data here. 
 
Methods 
We reviewed 79 consecutive actual GFR measurements from a cohort of 29 patients with 
common oncology conditions receiving nephrotoxic chemotherapy. Data was collected from 
the electronic medical record, including patient diagnosis, age, gender, weight, height, serum 
creatinine clearance and actual GFR. Four formulae were used to calculate eGFR, namely the 
Schwartz, revised Schwartz and Counahan-Barratt methods and, in addition, the height-
independent Pottel method [3]. To assess for correlations between these approaches and 
actual GFR, we compared the values obtained for each of the eGFR methods with the actual 
GFR by linear regression analysis (p<0.05 significant). We also undertook subgroup analyses 
for actual GFR measurements by gender (males=37, females=42) and patient weight 
(<10kgs=17, ≥10kgs=62). 
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Results 
The mean and standard deviation (range) of the cohort was 21.3±13.5 (0-80.0) kgs (weight), 
6.1±4.8 (0-16) years (age) and 104±20.5 (53-160) ml/min/1.73m
2
 (actual GFR). There was 
no significant positive correlation between any of the eGFR methods and actual GFR 
(Schwartz p=0.39, revised Schwartz p=0.17, Counahan-Barratt p=0.36 and Pottel p=0.96; 
R
2≤0.02 for all comparisons) (Figure 1), i.e. none of the formulae gave a reliable estimation 
of actual GFR. Furthermore, for children weighing <10kgs, the eGFR methods were even 
less reliable than for the cohort as a whole (data not shown). There were no differences by 
gender (data not shown). 
 
Discussion 
The use of simple formulae for estimating GFR in children is recommended for certain 
patient groups, such as those with chronic kidney disease, in order to monitor renal function 
during long-term follow-up [4]. Pediatric oncology patients require accurate determination of 
GFR for the safe dosing and delivery of nephrotoxic chemotherapy. The use of eGFR for this 
purpose is widespread. Of concern, the GFR may change acutely in the short-term in such 
patients, e.g. due to the concomitant use of other nephrotoxic agents such as antimicrobials. 
Until recently, available data on the appropriateness of eGFR methods for this group were 
limited. Our study, and that of Bernhardt et al [1], has confirmed that none of the currently 
used eGFR formulae gives values that are reliable compared with actual GFR in children with 
cancer. Consequently, we conclude that eGFR formulae are not safe to use to for 
chemotherapy dosing in such patients. 
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Legend to Figure 
 
Figure 1. 
Linear regression analysis comparing methods for estimating glomerular filtration rate 
(eGFR; y-axis) with the actual DTPA-based GFR measurement (x-axis) in a cohort of 
pediatric oncology patients. A) Schwartz method; B) Revised Schwartz method; C) 
Counahan-Barratt method and D) height-independent Pottel method. All GFR values 
represent ml/min/1.73m
2
. 
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